Who wants to be a millionaire? 3 ASX shares I think could make it happen

The allure of seven figures drives many investors. Here's an example of a way to grow your nest egg to that magic number.

| More on:
a couple clink champagne glasses on board a private aircraft with gourmet food plates set in front of them. They are wearing designer clothes and looking wealthy.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Fancy having a million dollars to your name?

Even though there is only a $5 difference between having $999,995 and having a seven-figure amount in your bank account, there is something about the title of "a millionaire" that continues to fascinate investors.

Well with the power of compounding and, of course, ASX shares, you can give the dream a red hot go.

Let's take a look at three stocks that you might consider for your portfolio:

Investing in mining without investing in mining

RPMGlobal Holdings Ltd (ASX: RUL) provides software and technology services to clients in the mining sector.

So it's a way to expose your portfolio to commodities without directly investing in a notoriously cyclical industry.

Created with Highcharts 11.4.3Johns Lyng Group PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

Analysts at Forager expressed their bullishness with RPMGlobal recently, saying the recent annual results showed cash flow and profit numbers are rapidly improving.

"Software revenue rose more than 50%, with 56% of that dropping through to the segment profit line," they wrote in a memo to clients.

"This is despite the company paying a management incentive during the year for software sales that will be mostly recognised as revenue in subsequent years."

While past performance is never an indicator of what will happen in the future, RPMGlobal shares have pleased its investors over the past five years, gaining 115% in value.

The business that's growing because of climate change

Insurance construction services provider Johns Lyng Group Ltd (ASX: JLG) has many fans among professional investors.

According to CMC Markets, eight out of 10 analysts currently rate the stock as a buy.

And that popularity continues even after the Johns Lyng share price has rocketed a phenomenal 626% over the past half-decade.

Created with Highcharts 11.4.3Johns Lyng Group PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

The Motley Fool's Tristan Harrison is bullish on the stock because of the changing weather patterns due to global warming.

"There seems to be a disappointing trend that there are more damaging and expensive weather events, which can be a tailwind for the level of the company's work and earnings," he said.

"I like that the business is looking to grow in different areas as well, including its move into strata/body corporate services, as well as 'essential home services', such as smoke alarm, electrical, gas compliance, testing and maintenance services."

Cancer treatments are needed the world over

Telix Pharmaceuticals Ltd (ASX: TLX) has doubled its share price over the past 12 months.

And no wonder, as it's rapidly moving its cancer diagnostic and treatment products from the research phase into trials and commercial release.

This is another company that's popular among those who invest for a living.

All seven analysts that cover Telix, as shown on CMC Markets, currently recommend the stock as a buy.

Created with Highcharts 11.4.3Telix Pharmaceuticals PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

The Motley Fool's James Mickleboro reported earlier this month that the Bell Potter team is one of those with a buy rating on the pharmaceutical company.  

"Bell Potter remains positive on the company's outlook and is forecasting second-half revenue of $274 million. This represents a 24% increase on its first-half revenues. 

"Looking further ahead, the broker sees multiple uses for PSMA PET agents beyond the label indications. It expects this to support its longer term growth."

Believe it or not, Telix shares have multiplied 13 times in value over the past five years.

A million bucks, here we come

So when can you call yourself a millionaire?

Looking at the five-year performance of the above trio, the median equates to a phenomenal compound annual growth rate (CAGR) of 48.66%.

Even if underperformance from the rest of the portfolio brought that rate down to 20% a year, seven figures is well within reach.

Assume you start with a $30,000 portfolio then you keep adding $300 each month.

After 17 years, that investment will have grown to $1,046,933.

And the best thing?

You only had to put in $91,200 of your money to get there. The rest of it was the sweet returns from the ASX shares plus compounding.

Motley Fool contributor Tony Yoo has positions in Johns Lyng Group and Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Johns Lyng Group, RPMGlobal, and Telix Pharmaceuticals. The Motley Fool Australia has recommended Johns Lyng Group, RPMGlobal, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Man sitting in a plane seat works on his laptop.
Opinions

Expert reveals 2 ASX stocks to sell — and 1 is a recent IPO

Toby Grimm from Baker Young shares his insights.

Read more »

An analyst wearing a dark blue shirt and glasses sits at his computer with his chin resting on his hands as he looks at the CBA share price movement today
Opinions

Expert's verdict on 3 ASX 200 shares (2 have doubled in value and the other has lost 29%)

Two of these stocks were the best performers of their sectors in FY25. Should you buy, hold, or sell?

Read more »

A male investor sits at his desk pondering at his laptop screen with a piece of paper in his hand.
Opinions

Where I'd invest in ASX shares ahead of the likely RBA rate cut

These stocks look too good to miss.

Read more »

Person pretends to types on laptop drawn in sand.
Opinions

I sold one of my oldest ASX 200 shares last week. Here's why

Why would I sell one of my longest-held stocks?

Read more »

Broker analysing the share price.
Materials Shares

Buy, hold, or sell? Broker's verdict on 3 ASX 200 materials shares

Materials was one of four market sectors that weakened in overall value in FY25.

Read more »

A person sitting at a desk smiling and looking at a computer.
Technology Shares

3 ASX 200 tech shares to buy in July: Experts

The ASX tech sector delivered outstanding returns for investors in FY25.

Read more »

A group of executives sit in front of computer screens in a darkened room while a colleague stands giving a presentation with a share price graphic lit up on the wall
Opinions

2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth

Shaw and Partners portfolio manager James Gerrish says he knows this will be an 'unpopular call'.

Read more »

Woman and man calculating a dividend yield.
Opinions

Buy or bail? Fundie's verdict on 2 ASX 300 shares

Stuart Bromley of Medallion Financial Group provides his insights.

Read more »